Compares treatment options for Rectal Cancer
Official title Virtual Ileostomy Versus Diverting Ileostomy in Patients Undergoing Total Mesorectal Excision
ClinicalTrials.gov ID: NCT06633133
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn to compare the safety and efficacy of virtual ileostomy versus diverting ileostomy in patients undergoing sphincter-saving surgery for rectal cancer. The main questions it aims to answer are: Is the virtual ileostomy a safe and effective alternative to the ileostomy?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Diagnosis of rectal cancer confirmed by pathology
- Age ≥ 18 years
- Total mesorectal excision (TME) surgical procedures and colon-rectum or colon-anal anastomosis:1.anterior resection (AR/ PME), 2. low anterior...
- Signed informed consent
- Ability to understand the nature and risks of participating in the trial
You likely can't join if
- Emergency surgery, open surgery
- ASA score \>3points
- Patients with combined complete intestinal obstruction
- Long-term history of using immunosuppressants or glucocorticoids
- Combined severe cardiac disease: with congestive heart failure or NYHA cardiac function ≥ grade 2. Patients with a history of myocardial infarction...
- Chronic renal failure (requiring dialysis or glomerular filtration rate \<30 mL/min)
See the full eligibility criteria
- Diagnosis of rectal cancer confirmed by pathology
- Age ≥ 18 years
- Total mesorectal excision (TME) surgical procedures and colon-rectum or colon-anal anastomosis:1.anterior resection (AR/ PME), 2. low anterior resection (LAR) , 3.intersphincteric abdominoperineal resection (ISR)...
- Signed informed consent
- Ability to understand the nature and risks of participating in the trial
- Emergency surgery, open surgery
- ASA score \>3points
- Patients with combined complete intestinal obstruction
- Long-term history of using immunosuppressants or glucocorticoids
- Combined severe cardiac disease: with congestive heart failure or NYHA cardiac function ≥ grade 2. Patients with a history of myocardial infarction or coronary artery surgery within 6 months before the procedure
- Chronic renal failure (requiring dialysis or glomerular filtration rate \<30 mL/min)
- Intraoperative combined multi-organ resection
- Combined cirrhosis of the liver
- Intraoperative findings of incomplete anastomosis and positive insufflation test
- Modified Bacon procedure(Two-Stage Turnbull-Cutait Pull-Through Coloanal Anastomosis)
- Due to an intraoperative accident the surgeon felt that a diverting ileostomy was necessary.
- Currently participating in other clinical trials
The study team makes the final eligibility decision.
Where it's taking place
- Chongqing, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chongqing, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.